TMCnet News
CRO Quality Benchmarking - Phase II/III Service Providers (2016 Edition) - Research and MarketsResearch and Markets has announced the addition of the "CRO Quality Benchmarking - Phase II/III Service Providers (8th edition)" report to their offering. The CRO Quality Benchmarking - Phase II/III Service Providers report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied performance ratings based on their own experiences with 44 Phase II/III CROs, making this report the most comprehensive assessment of CRO service quality in the industry. Now in its 8th year, this report has become a crucial tool for sponsors looking to select a Phase IV CRO and for service providers seeking an experience-based evaluation of their strengths and weaknesses. Study Sponsors: - Make a more informed purchase of Phase II/III services by understanding which service providers best fit your company's needs - Broaden your Phase IV CRO evaluation list by accessing peer-based service quality ratings across 26 critical attributes - Pinpoint potential delivery concerns early in a sponsor-CRO relationship/ evaluation in order todevelop proactive strategies to address potential gaps Clinical Service Providers: - Uncover your own - and competitor - delivery strengths and weaknesses - Design messaging to tout your company's strengths - Compete more effectively by understanding buyers' selection criteria and outsourcing trends Key Topics Covered: 1. Introduction 2. Methodology 3. Respondent Demographics And Qualifications 4. Number Of Ratings Per Company 5. 5 Major Sections 6. Service Provider Selection Process 7. Service Provider Perceptions And Interactions (News - Alert) 8. Service Provider Performance And Loyalty 9. Company Service Quality Profiles 10. Study Data 11. Demographics Companies Mentioned
For more information about this report visit http://www.researchandmarkets.com/research/6mkltf/cro_quality
View source version on businesswire.com: http://www.businesswire.com/news/home/20161130005586/en/ |